Skip to content

Climb Bio, Inc. CLYM Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
-$39.92M+10.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$50.67M-3.9%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
-$40.84M-7.0%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-$14.77M-7.8%
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
-$23.64M-17.1%
Alumis Inc. logo
Alumis Inc.ALMS
-$93.71M+5.4%

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$724.95M+787%
Enterprise value$717.07M+1,247%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Bio, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
Climb Bio, Inc. (CLYM) reported comprehensive income (loss), net of tax, attributable to parent of -$14M in Q1 2026.
How has Climb Bio, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
Climb Bio, Inc.'s comprehensive income (loss), net of tax, attributable to parent increased by 31.8% year-over-year, from -$20.52M to -$14M.
What is the long-term trend for Climb Bio, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
Over 4 years (2021 to 2025), Climb Bio, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 5.7% compound annual growth rate (CAGR), from -$47.6M to -$59.44M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
This metric captures the change in equity resulting from revenues, expenses, gains, and losses that are excluded from net income under accounting standards. It includes items such as unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments. Analyzing this figure provides a more comprehensive view of the company's total financial performance and the impact of market volatility on its balance sheet.